Related Experiment Video
Updated: Aug 16, 2026
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Published on: August 28, 2013
Prostate carcinoma: production of bioactive factors
1Department of Medicine, University of California-San Diego and the San Diego Veterans Affairs Medical Center, USA.
Background:
Many molecular mechanisms regulate prostate carcinoma pathogenesis, proliferation, and progression to bone metastases. The basic molecular mechanisms are endocrine, paracrine, autocrine, and intracrine. These mechanisms can be mediated by a variety of agents, including gonadal and adrenal steroids, retinoic acid and vitamin D derivatives, neuroendocrine factors, growth factors, cytokines, lymphokine, and bone factors. Prominent among them is parathyroid hormone-related protein (PTHrP).
Methods:
The author studied the expression and regulation of PTHrP production in prostate carcinoma cells with nucleic acid and immunochemical probes for the polypeptide. The robust expression of this oncoprotein by prostate carcinoma has been demonstrated. In the current study the author reviews his results and the studies of other investigators regarding PTHrP and the variety of bioactive factors produced by prostate cells.
Results:
PTHrP is expressed by most prostate carcinoma. It also is expressed by normal and hyperplastic prostate cells, and there is a gradient of expression that peaks in malignant prostate cells. PTHrP is processed by carcinoma cells into peptides that have unique biologic effects. Among them are regulation of growth and cytokine expression. It has been observed that the effect of PTHrP can be mediated by novel intracrine pathways in prostate carcinoma. These mechanisms influence transduction of growth regulatory signaling pathways, cell proliferation, immunoregulation, and angiogenesis.
Conclusions:
The current study identified PTHrP among the bioactive prostate factors that appear to participate in prostate carcinoma pathogenesis and progression. This oncofetal protein is commonly expressed by prostate carcinoma, and its regulatory interactions with other bioactive prostate cell products play an important role in the pathobiology of prostate carcinoma. Understanding these regulatory interactions among prostate carcinoma, its cell products, and the skeleton continues to provide insights into the pathogenesis of this disease entity and may provide clues to clinical management.
Insights
Parathyroid hormone-related protein (PTHrP) is highly expressed in prostate carcinoma and influences cell growth, proliferation, and angiogenesis. Understanding PTHrP’s role offers insights into prostate cancer progression and potential clinical management strategies.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Prostate carcinoma pathogenesis involves complex molecular mechanisms including endocrine, paracrine, autocrine, and intracrine signaling.
- Various agents like steroids, vitamin D derivatives, growth factors, and cytokines mediate these mechanisms.
- Parathyroid hormone-related protein (PTHrP) is a key factor in prostate carcinoma.
Purpose of the Study:
- To investigate the expression and regulation of PTHrP in prostate carcinoma cells.
- To review existing studies on PTHrP and other bioactive factors in prostate cells.
Main Methods:
- Utilized nucleic acid and immunochemical probes to study PTHrP expression and regulation.
- Reviewed and synthesized results from the author's studies and other investigators' research.
Main Results:
- PTHrP is robustly expressed in most prostate carcinomas, with expression peaking in malignant cells.
- Prostate carcinoma cells process PTHrP into peptides that regulate growth and cytokine expression.
- PTHrP effects are mediated by intracrine pathways influencing signaling, proliferation, immunoregulation, and angiogenesis.
Conclusions:
- PTHrP is a significant bioactive factor in prostate carcinoma pathogenesis and progression.
- Its interactions with other prostate cell products are crucial for the disease's pathobiology.
- Understanding these interactions provides insights into prostate cancer pathogenesis and clinical management.
Related Concept Videos
02:17The Tumor Microenvironment
01:25Mutagenicity and Carcinogenicity